Drdgold Ltd-sponsored Adr (DRD) Institutional Investor Snapshot (105 Funds, Q2 2026)

DRD ranks #4489 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

105 institutions disclose a position in DRD, but none treat it as a major bet — even Towarzystwo Funduszy Inwestycyjnych Allianz Polska S.A., its most concentrated holder, allocates just 0.9% of its own portfolio to it.

Blue Trust, Inc. has trimmed its DRD position for two straight quarters, cutting it by $83.8K while still holding $1.1K.

DRD is up 2% today, but institutions show net selling of $22.7M this quarter — a divergence between today's price move and the underlying institutional flow.

DRD closed its latest fiscal year with net income of $2.2B.

• Profitable — net income of $2.2B in the latest fiscal year
• Revenue grew 26.3% year over year
• Net income improved year over year, from $1.3B to $2.2B
• Generated $3.5B in positive operating cash flow
• Current ratio of 2.28x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.38x equity — within a conventional range